Time to response to citalopram treatment for agitation in Alzheimer's disease

BACKGROUND: Agitation is a common and significant problem in Alzheimer’s disease (AD). In the recent Citalopram for Agitation in Alzheimer’s Disease (CitAD) study, citalopram was efficacious for the treatment of AD agitation. Here we examined the time course and predictors of response to treatment....

Full description

Saved in:
Bibliographic Details
Published in:Am J Geriatr Psychiatry
Main Authors: Weintraub, Daniel, Drye, Lea T., Porsteinsson, Anton P., Rosenberg, Paul B., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Schneider, Lon S., Shade, David M., Yesavage, Jerome, Lyketsos, Constantine G.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4653092/
https://ncbi.nlm.nih.gov/pubmed/26238225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2015.05.006
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items